<DOC>
	<DOCNO>NCT00327704</DOCNO>
	<brief_summary>Objective : To determine whether early administration albumin expander antioxidant would improve survival 28th day septic shock patient . Design : Prospective , multicenter , randomize , control versus saline , stratify nosocomial infection center . Setting : 27 Intensive Care Units ( ICU ) France Coordinator : Pr J.P. Mira Dr J. Charpentier - Cochin Hospital- Paris Patients : 800 patient could include first 6 hour septic shock .</brief_summary>
	<brief_title>Early Albumin Resuscitation During Septic Shock</brief_title>
	<detailed_description>The primary outcome : Mortality 28 day period randomization . The secondary outcome : Evaluation SOFA score , ventilator-free day , dialysis free day , catecholamine free day , day hospitalisation , incidence nosocomial infection . The albuminemia patient request treatment Day 4 post treatment . The treatment : Vialebex 20 % 100ml every 8 hour 3 day versus saline 100ml every 8 hour 3 day . The first patient July 2006 , last patient expect July 2009 .</detailed_description>
	<mesh_term>Shock</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<criteria>Over 18 year old Septic shock &lt; 6 hour Agreement patient Allergy albumin Weight &gt; 120 kg Non septic shock Burned Cirrhosis Albumin perfusion 48 hour randomization Pregnant woman Cardiac dysfunction New York Heart Association ( NYHA ) 3 4 Patients therapeutic limitation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Septic Shock</keyword>
</DOC>